---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-25-000121"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2025-07-29T23:59:59+00:00"
generated_at: "2026-05-17T23:46:18.413820+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Immunovant finalizes CEO Eric Venker's employment agreement with $672K salary, equity awards

## Summary
- Annual base salary $672,000; target annual bonus 72.25% of base salary.
- Option Awards: 1,300,000 stock options and options valued at $2,250,000 (189,900 shares), four-year vest.
- CVAR Award: 1,475,000 capped appreciation rights with performance and $16.76 stock price hurdle.
- Two-year holding period on vested shares from Unit Option Award and 87.25% of CVAR-settled shares.
- Severance: 12 months salary + target bonus + COBRA if terminated without cause or for good reason.

## SEC filing metadata
- accession: 0001764013-25-000121
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2025-07-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000121/0001764013-25-000121-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000121/imvt-20250728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-25-000121
- JSON: https://secwatch.observer/filing/0001764013-25-000121.json
- Plain text: https://secwatch.observer/filing/0001764013-25-000121.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.